Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-03-05Clinical Trial Update: IMPact of AerobiC Exercise in Addition to Nutritional Treatment on Quality of Life After Pancreatectomy [NA]
A clinical trial evaluating whether aerobic exercise added to nutritional treatment improves quality of life after pancreatectomy; the study…
-
EMA approval · 2025-03-05EMA Authorised: Tarceva (erlotinib) — Cheplapharm Registration GmbH
Tarceva (erlotinib) has been authorised in the EU with Cheplapharm Registration GmbH as the marketing authorisation holder for non-small cel…
-
CLINICAL_TRIALS research · 2025-03-03Clinical Trial Update: Lidocaine Infusion in Pancreatic Cancer [EARLY_Phase 1]
This entry reports an early Phase 1 clinical trial evaluating lidocaine infusion for pancreatic cancer, currently recruiting.
-
CLINICAL_TRIALS research · 2025-02-28Clinical Trial Update: Neoantigen Vaccine Plus Anti-PD1 and Chemotherapy as an Adjuvant Therapy for Pancreatic Cancer [Phase 1]
This Phase 1 clinical trial evaluates a neoantigen vaccine plus anti-PD1 therapy and chemotherapy as adjuvant treatment for pancreatic cance…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update for XB2001 in combination with ONIVYDE and 5-FU/leucovorin in advanced pancreatic cancer; the Phase 1/2 study is liste…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
-
CLINICAL_TRIALS other · 2025-02-26Clinical Trial Update: A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer [Phase 1, Phase 2]
A Phase I/IIa study of EF-009 for pancreatic cancer is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: Adapted Guided Stereotactic Body Radiotherapy Combined with Chemotherapy and Enhancement of Novel Drug Ivonescimab for Pancreatic Cancer (ASCEND) [Phase 1, Phase 2]
A Phase 1/2 trial from Shandong Cancer Hospital and Institute is evaluating adapted guided stereotactic body radiotherapy with chemotherapy …
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Chemoradiotherapy in Elderly Patients with Locally Advanced Pancreatic Cancer (70+).
A clinical trial update investigating chemoradiotherapy for elderly (70+) patients with unresectable locally advanced pancreatic cancer; the…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: Clinical Application of PET Imaging Targeting MSLN in Malignant Tumors
This entry describes an ongoing clinical trial evaluating an MSLN-targeted PET imaging tracer for malignant tumors, with recruitment underwa…
-
CLINICAL_TRIALS research · 2025-02-25Clinical Trial Update: American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
An ongoing registry for pancreatic cancer patients treated with irreversible electroporation (IRE), sponsored by the University of Louisvill…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours [Phase 1]
Phase 1 first-in-human study to evaluate safety, tolerability and antineoplastic activity of OATD-02 in patients with selected advanced/meta…
-
CLINICAL_TRIALS trial_result · 2025-02-21Clinical Trial Update: Metformin and Insulin to Pancreatic Cancer Related Diabetes (Type 3c) [Phase 2]
A Phase 2 clinical trial from Fudan University evaluating metformin and insulin in patients with pancreatic cancer–related diabetes (Type 3c…
-
CLINICAL_TRIALS withdrawal · 2025-02-21Clinical Trial Update: QUILT-3.088: NANT Pancreatic Cancer Vaccine [Phase 2]
A Phase 2 trial of the NANT Pancreatic Cancer Vaccine (QUILT-3.088) for metastatic pancreatic cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2025-02-21Clinical Trial Update: INSPIRE: a Multi-Cancer Early Detection Study
INSPIRE is a multi-cancer early detection clinical trial that is currently recruiting and evaluating detection across multiple cancer types.…
-
CLINICAL_TRIALS trial_result · 2025-02-19Clinical Trial Update: Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]
A Phase 2 trial evaluating pembrolizumab with the CXCR4 antagonist BL-8040 in metastatic pancreatic cancer has completed, with results poste…
-
CLINICAL_TRIALS research · 2025-02-19Clinical Trial Update: Effects of Aromatherapy with Essential Oils on Anxiety and Depression in Perioperative Patients with Pancreatic Cancer [NA]
This clinical trial evaluates whether aromatherapy with essential oils can reduce anxiety and depression in perioperative patients with panc…
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic Surgery [Phase 4]
A Phase 4 clinical trial evaluating preoperative versus postoperative thromboprophylaxis in pancreatic surgery for pancreatic cancer.
-
CLINICAL_TRIALS research · 2025-02-14Clinical Trial Update: Irinotecan Liposome in Combination With Capecitabine [NA]
Clinical trial evaluating liposomal irinotecan in combination with capecitabine for pancreatic cancer is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Carbon Ions Radiation Therapy for Resectable or Borderline Resectable Pancreas Adenocarcinoma [Phase 2]
A Phase 2 trial evaluating carbon ion radiotherapy for resectable or borderline resectable pancreatic cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-13Clinical Trial Update: Education Intervention in Patients with Rash Due to Epidermal Growth Factor Receptor (EGFR) Treatment. [NA]
This clinical trial update describes an education intervention aimed at helping patients manage rash associated with epidermal growth factor…
-
CLINICAL_TRIALS research · 2025-02-13Clinical Trial Update: Effect of Geriatric Intervention in Frail Patients with Gastric, Biliary, and Pancreatic Cancer Receiving Palliative Chemotherapy [NA]
This update describes an ongoing clinical trial evaluating a geriatric intervention for frail patients with gastric, biliary tract (cholangi…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: A Pivotal Study of Safety and Effectiveness of NanoKnife IRE for Stage 3 Pancreatic Cancer [Phase 3]
A pivotal Phase 3 trial is examining the safety and effectiveness of NanoKnife Irreversible Electroporation for Stage III pancreatic cancer.…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy, Phase 1 Study of CMG901 [Phase 1]
This Phase 1 study of CMG901 in patients with advanced solid tumors, including gastric cancer and pancreatic cancer, assesses safety, tolera…
-
CLINICAL_TRIALS trial_result · 2025-02-12Clinical Trial Update: LYT-200 Alone and in Combination With Chemotherapy or Tislelizumab in Patients With Locally Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
Phase 1/2 clinical trial update of LYT-200 as a single agent and in combination with chemotherapy or tislelizumab in locally advanced or met…